- Home
- FORTY vs AUPH Comparison
FORTY vs AUPH Comparison
Compare FORTY & AUPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FORTY
- AUPH
- Stock Information
- Founded
- FORTY 1985
- AUPH 1993
- Country
- FORTY Israel
- AUPH Canada
- Employees
- FORTY N/A
- AUPH N/A
- Industry
- FORTY EDP Services
- AUPH Biotechnology: Pharmaceutical Preparations
- Sector
- FORTY Technology
- AUPH Health Care
- Exchange
- FORTY Nasdaq
- AUPH Nasdaq
- Market Cap
- FORTY 1.2B
- AUPH 1.0B
- IPO Year
- FORTY 1997
- AUPH 1999
- Fundamental
- Price
- FORTY $80.05
- AUPH $8.12
- Analyst Decision
- FORTY
- AUPH Strong Buy
- Analyst Count
- FORTY 0
- AUPH 3
- Target Price
- FORTY N/A
- AUPH $10.33
- AVG Volume (30 Days)
- FORTY 617.0
- AUPH 1.3M
- Earning Date
- FORTY 11-25-2024
- AUPH 11-07-2024
- Dividend Yield
- FORTY 1.58%
- AUPH N/A
- EPS Growth
- FORTY 4.36
- AUPH N/A
- EPS
- FORTY 4.32
- AUPH N/A
- Revenue
- FORTY $2,661,211,000.00
- AUPH $220,361,000.00
- Revenue This Year
- FORTY N/A
- AUPH $36.52
- Revenue Next Year
- FORTY N/A
- AUPH $19.02
- P/E Ratio
- FORTY $18.67
- AUPH N/A
- Revenue Growth
- FORTY 1.94
- AUPH 38.72
- 52 Week Low
- FORTY $58.29
- AUPH $4.71
- 52 Week High
- FORTY $87.70
- AUPH $10.05
- Technical
- Relative Strength Index (RSI)
- FORTY 45.04
- AUPH 62.64
- Support Level
- FORTY $77.50
- AUPH $8.06
- Resistance Level
- FORTY $81.20
- AUPH $8.70
- Average True Range (ATR)
- FORTY 0.57
- AUPH 0.34
- MACD
- FORTY -0.82
- AUPH 0.07
- Stochastic Oscillator
- FORTY 25.00
- AUPH 63.74
About FORTY Formula Systems (1985) Ltd.
Formula Systems (1985) Ltd is a holding company that, through its subsidiaries, provides information technology services. The company organizes itself into operating segments: The Matrix segment, which generates the majority of revenue, provides software development and existing software expansion services. The Sapiens segment provides software development services for the insurance industry. The Magic Software segment provides vendor management systems and workforce management services, which include accounting and finance, human resources; Michpal; ZAP Group and Others. The majority of the company's revenue comes from Israel.
About AUPH Aurinia Pharmaceuticals Inc
Aurinia Pharmaceuticals Inc is a biopharmaceutical company. It provides products for patients suffering from serious diseases with a high unmet medical need. The firm is developing LUPKYNIS (voclosporin), an investigational drug, for the treatment of lupus nephritis (LN), and others. Geographically, it derives maximum revenue from the United States.